SCITERIONSCITERIONSCITERIONSCITERION
  • About
  • Culture
  • Join
  • Blog
  • Contact
✕
Sciterion wins 2015 Communique Award for excellence in meetings
11 September 2015

Medical Affairs key to rapid medicines adoption

Published by Sciterion on 1 September 2015
Categories
  • Uncategorised
Tags

Due to rigorous regulatory demands and the need for many years of safety and efficacy research, most medicines only have commercial patent protected lifespans of 10-12 years. This means that the speed of medicines adoption, following regulatory approval, is vitally important to pharmaceutical companies. While there are many factors that affect uptake, Medical Affairs teams are rapidly becoming the one of the most important facilitators of medical innovation adoption.

To understand why the role of Medical Affairs is so important in facilitating adoption, we first need to understand the mechanics of innovation diffusion. Everett Rogers’ book Diffusion of Innovations and the later work of Jeff More Crossing the Chasm sets out a clear model for understanding the process by which an innovation is communicated over time through the members of a specific community. It defines the role of five key groups in spreading innovation:

  • Innovators (2.5% of the population) – those discovering, or in close contact with, new scientific breakthroughs. They are not scared to take risks and have a desire to break new ground.
  • Early adopters (13.5% of the population) – individuals with the highest degree of opinion leadership among the other adopter groups. They have a high professional status and are more discrete in their adoption choices than innovators.
  • Early Majority (34% of the population) – adopt an innovation after the innovators and early adopters have advocated and established the credibility and value of a product.
  • Late Majority (34% of the population) – this category approach an innovation with a high degree of scepticism and tend only to adopt a product once it is very well established and used by at least 50% of their peer group.
  • Laggards (16% of the population) – the last to adopt an innovation. This group typically have an aversion to change-agents and tend to be focused on the traditional established approach.

The model intuitively makes sense in healthcare setting. If the Innovators (the clinical study leads, clinical paper authors and research investigators) are not advocating and communicating about a new medicine then the Early Adopters (the people who traditionally educate their peers about emerging treatments through congresses and educational meetings) will either not find out about, or not support and communicate about, an innovative new medicine. Without the active advocacy of Early Adopters it is extremely difficult to establish credibility for a new medicine. The Majority will simply see it as too risky to and unproven to try and uptake will either be slow or in some cases never reach a critical mass.
Once the importance of the knowledge, or advocacy cascade, is understood it becomes obvious why Medical Affairs is so important. Their role in organising:

  • study investigator meetings
  • publications
  • educational meetings
  • congresses and symposia speakers…

…is vital to coordinating Innovators and Early Adopters to share their knowledge and experience with peers. These activities ensure the smooth and timely transition of knowledge from the experts to the broader HCP audience, allowing innovations to achieve rapid and wide uptake. In an environment where delivering innovation is a race to recoup the huge cost of medicines research and development the role Medical Affairs teams as innovation facilitators can only grow in importance and recognition.

Share
8

Find

SCITERION

Ferry Works
Summer Road
Thames Ditton
Surrey, UK
KT7 0QJ
enquiries@sciterion.com
+44 203 675 3975

Ask

Gabi Cutayar
Managing Director
gabi.cutayar@sciterion.com
+44 (0) 203 675 3969

© 2021 Sciterion. All Rights Reserved. Terms of use | Data protection policy | Cookie policy

Cookie Settings
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. Click "Cookie Settings" to provide a controlled consent. Read our cookie policy
Cookie SettingsAccept AllReject All
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-advertisement1 yearSet by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Advertisement" category .
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
CookieLawInfoConsent1 yearRecords the default button state of the corresponding category & the status of CCPA. It works only in coordination with the primary cookie.
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
CookieDurationDescription
_ga2 yearsThe _ga cookie, installed by Google Analytics, calculates visitor, session and campaign data and also keeps track of site usage for the site's analytics report. The cookie stores information anonymously and assigns a randomly generated number to recognize unique visitors.
_gat_gtag_UA_69063891_11 minuteSet by Google to distinguish users.
_gid1 dayInstalled by Google Analytics, _gid cookie stores information on how visitors use a website, while also creating an analytics report of the website's performance. Some of the data that are collected include the number of visitors, their source, and the pages they visit anonymously.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT
Powered by CookieYes Logo